299
Views
14
CrossRef citations to date
0
Altmetric
Reviews

Controversies in the use of insulin analogues

, , &
Pages 199-209 | Published online: 10 Jan 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Norbert Tennagels & Ulrich Werner. (2013) The metabolic and mitogenic properties of basal insulin analogues. Archives of Physiology and Biochemistry 119:1, pages 1-14.
Read now
Zhulin Ma, Tina Parkner, Jens Sandahl Christiansen & Torben Laursen. (2012) IDegAsp: a novel soluble insulin analogs combination. Expert Opinion on Biological Therapy 12:11, pages 1533-1540.
Read now
Katherine Esposito & Dario Giugliano. (2012) Current insulin analogues in the treatment of diabetes: emphasis on type 2 diabetes. Expert Opinion on Biological Therapy 12:2, pages 209-221.
Read now

Articles from other publishers (11)

M.V. Neborachko & O.G. Phakadze. (2021) Does all the evidence say that insulin analogues are more effective than human insulins?. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) 17:7, pages 581-588.
Crossref
Daniel Aizen, Metsada Pasmanik-Chor, Rive Sarfstein, Zvi Laron, Ilan Bruchim & Haim Werner. (2018) Genome-Wide Analyses Identify Filamin-A As a Novel Downstream Target for Insulin and IGF1 Action. Frontiers in Endocrinology 9.
Crossref
Chen Zhou, Wei Qi, E. Neil Lewis & John F. Carpenter. (2016) Characterization of Sizes of Aggregates of Insulin Analogs and the Conformations of the Constituent Protein Molecules: A Concomitant Dynamic Light Scattering and Raman Spectroscopy Study. Journal of Pharmaceutical Sciences 105:2, pages 551-558.
Crossref
Daniel Aizen, Rive Sarfstein, Ilan Bruchim, Doron Weinstein, Zvi Laron & Haim Werner. (2015) Proliferative and signaling activities of insulin analogues in endometrial cancer cells. Molecular and Cellular Endocrinology 406, pages 27-39.
Crossref
R. F. Castro, L. A. Azzalis, D. Feder, F. F. Perazzo, E. C. Pereira, V. B. C. Junqueira, K. C. Rocha, C. D’A. Machado, F. C. Paschoal, L. A. Gnann & F. L. A. Fonseca. (2012) Safety and efficacy analysis of liposomal insulin-like growth factor-1 in a fluid gel formulation for hair-loss treatment in a hamster model. Clinical and Experimental Dermatology 37:8, pages 909-912.
Crossref
Anastasia N. Mavrogiannaki & Ilias N. Migdalis. (2012) Long-acting basal insulin analogs: latest developments and clinical usefulness. Therapeutic Advances in Chronic Disease 3:6, pages 249-257.
Crossref
Matthias Evert, Diego F. Calvisi, Katja Evert, Valentina De Murtas, Gioia Gasparetti, Sandra Mattu, Giulia Destefanis, Sara Ladu, Antje Zimmermann, Salvatore Delogu, Sara Thiel, Andrea Thiele, Silvia Ribback & Frank Dombrowski. (2012) V-AKT murine thymoma viral oncogene homolog/mammalian target of rapamycin activation induces a module of metabolic changes contributing to growth in insulin-induced hepatocarcinogenesis. Hepatology 55:5, pages 1473-1484.
Crossref
Ingo Stammberger & Luc Essermeant. (2012) Insulin Glargine: A Reevaluation of Rodent Carcinogenicity Findings. International Journal of Toxicology 31:2, pages 137-142.
Crossref
Xi-Lin Yang. (2012) Diabetes, insulin and cancer risk. World Journal of Diabetes 3:4, pages 60.
Crossref
Andrew J. Krentz & Alan J. Sinclair. (2011) Choice of Long-Acting Insulin Therapy for Type 2 Diabetes. Drugs & Aging 28:12, pages 935-941.
Crossref
Harald G Enzmann & Martina Weise. (2011) Current european regulatory perspectives on insulin analogues. Diabetology & Metabolic Syndrome 3:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.